WJPR Citation

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar. Best Paper Award : Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

PROGNOSIS, RESPONSE TO TREATMENT OF HIGH RISK GTN DISEASE DUE TO POSSIBLE RISK FACTOR: IS BLOOD TYPE EFFECTIVE ON RESPONSE TO THE TREATMENT?

Fatemeh Cheraghi and *Khatereh Hekmatnia

ABSTRACT

Introduction: Gestational trophoblastic disease or GTD includes a
diverse group of neoblastic disorders that arise from epithelial
trophoblastic of placenta and is characterized by high levels of blood
βHCG. Researchers are trying to find more information about the
markers associated with this disease to find better prognosis and a
greater understanding of the disease. One of the markers focused by
researchers in various fields of medical science is the blood type. In
this research we studied high risk GTN patients (gestational
trophoblastic neoplasia) with the aim of surveying prevalence of the
disease based on blood type. Method: In a cross-sectional study of
descriptive analysis with the aim of determining the effect of blood
type on prevalence of high risk GTN disease and also its effect on the
response to treatment, 160 patients and case files were examined, 37
cases of which were excluded due to factors such as lack ofcooperation and missing
documents. Then a questionnaire consisting of patient's demographic data, blood type, type of
GTD and the patient's response to treatment was prepared, and the information were recorded
in questionnaires and analyzed for selected patients. Results: Blood types of patients were
often O and A. 69 people had blood group A who constitute 56.1%. The number of people
with O blood group was 33 who constituted 26.8%. 21 people with blood type B/AB
constituted 17.1%. The chance of treatment response showed no significant difference in any
of the various blood groups (P> 0.05). Conclusion: Gestational trophoblastic disease is more
common in patients with blood types A and O but the chance of treatment response in these patients was not significantly associated with blood type, of course, to cite more accurate
results, more research is needed in different societies.